Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#How Will The Asthma Drugs Market Valuation Change Between Now And 2029?#_x000D_

In recent years, the asthma drugs market has seen consistent growth. The market size is predicted to increase from $23.96 billion in 2024 to $24.93 billion in 2025, showing a compound annual growth rate (CAGR) of 4.0%. This upward trend in the historical period can be credited to environmental influences, an uptick in respiratory disorders, lifestyle modifications, and the development of healthcare infrastructure._x000D_

_x000D_

We anticipate a solid expansion in the asthma drugs market in the approaching years. The market is projected to scale up to “$31.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.9%. Factors contributing to this predicted growth include escalating air pollution, an expanding elderly population, improved awareness of healthcare, trends in personalized medicine, and innovations in biopharmaceuticals. During the forecast period, the market will be influenced by evolving trends such as the growth of small molecule therapies, the shift towards home-based asthma care, the implementation of biomarker-guided therapies, advancements in severe asthma therapies, and partnerships aimed at asthma research._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=11924&type=smp_x000D_

_x000D_

#Which Growth Drivers Are Shaping The Asthma Drugs Market Outlook?#_x000D_

The rise in asthmatic conditions is projected to spur the expansion of the asthma drug market. Asthma is a chronic illness that causes inflammation and swelling of the airways, leading to the narrowing of the passages that transport air from the mouth and nose to the lungs. Due to the escalating rates of asthma, there is a growing focus on the development of new drugs for the treatment of these conditions. For example, as reported by the Asthma + Lung UK, a UK-based charity that supports individuals with lung disorders, there were 1,146 recorded deaths linked to asthma in England in 2021. This figure experienced a rise in 2022, escalating to 1,236, depicting a worrisome increase in death rates related to the illness over the span of the year._x000D_

_x000D_

#How Is The Asthma Drugs Market Segmented Across Key Categories?#_x000D_

The asthma drugs market covered in this report is segmented – _x000D_

_x000D_

1) By Type Of Asthma: Allergic, Non-Allergic_x000D_

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma_x000D_

3) By Therapy: Preventive, Curative_x000D_

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs_x000D_

5) By End-User: Asthma Patients, COPD Patients_x000D_

_x000D_

Subsegments:_x000D_

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies _x000D_

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids _x000D_

_x000D_

#What Key Trends Are Driving Growth In The Asthma Drugs Market?#_x000D_

Significant corporations in the asthma drugs market are prioritizing groundbreaking innovations such as fixed-dose combination (FDC) drugs to improve the efficiency of treatments and the compliance of patients. An FDC drug is a medication that bundles two or more active components into one dosage form like a tablet, capsule, or inhaler. For instance, Glenmark Pharmaceuticals, a pharmaceutical firm based in India, introduced Indamet, an FDC drug for uncontrolled asthma patients in India, in June 2022. This progressive treatment merges Indacaterol, a long-acting beta-agonist, with Mometasone Furoate, an inhaled corticosteroid. It is accessible in various strengths, featuring Indacaterol 150 mcg with Mometasone in doses of 80 mcg, 160 mcg, and 320 mcg. Indamet, which is planned for once-daily use, is aimed at adults and adolescents who are 12 years or older._x000D_

_x000D_

#Who Are The Leading Companies Driving The Asthma Drugs Market?#_x000D_

Major companies operating in the asthma drugs market include Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd, Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc., Atopix Therapeutics Limited _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report_x000D_

_x000D_

#Which Region Dominates The Asthma Drugs Market Today?#_x000D_

North America was the largest region in the asthma drugs market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=11924&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model